BioLife Solutions, Inc. (NASDAQ:BLFS) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Troy Wichterman - Chief Financial Officer Mike Rice - Chairman and Chief Executive Officer Rod de Greef - President and Chief Operating Officer Conference Call Participants Thomas Flaten - Lake Street Capital Markets Hannah Hefley - Stephens Max Masucci - Cowen and Company Suraj Kalia - Oppenheimer Operator Good day. My name is Chantel, and I'll be your conference operator today. At this tim ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3076866 (State or other jurisd ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3076866 (State or other juris ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Troy Wichterman - Chief Financial officer Mike Rice - Chairman and Chief Executive Officer Rod De Greef - President and Chief Operating Officer Conference Call Participants Max Masucci - Cowen and Company Jacob Johnson - Stephens Inc. Thomas Flaten - Lake Street Capital Markets Suraj Kalia - Oppenheimer Operator Welcome to the BioLife Solutions First Quarter 2022 Financial Results Conference Ca ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36362 BioLife Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3076866 (State or other jurisd ...

Investor Presentation Acquisition of: March 2022 NASDAQ : BLFS 1 BioLife Solutions Investor Presentation : March 2022 NASDAQ: BLFS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2021 Results Conference Call February 28, 2022 4:30 PM ET Company Participants Mike Rice - Chairman and Chief Executive Officer Troy Wichterman - Chief Financial officer Roderick De Greef - President and Chief Operating Officer Conference Call Participants Max Masucci - Cowen and Company Paul Knight - KeyBanc Jacob Johnson - Stephens Thomas Flaten - Lake Street Capital Yuan Zhi - Riley Securities Mike Okunewitch - Maxim Mike Ott - Oppenheimer Operator Ladies and gent ...

Investor Presentation Acquisition of: November 2021 NASDAQ : BLFS 1 BioLife Solutions Investor Presentation : November 2021 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...

Table of Contents Title of each class Trading symbol Name of exchange on which registered BioLife Solutions, Inc. Common Shares BLFS NASDAQ Capital Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F ...

BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2021 Earnings Conference Call November 12, 2021 4:30 PM ET Company Participants Mike Rice – Chairman and Chief Executive Officer Troy Wichterman – Chief Financial officer Roderick De Greef – President and Chief Operating Officer Conference Call Participants Max Masucci – Cowen and Company Jacob Johnson – Stephens Paul Knight – KeyBanc Yuan Zee – B. Riley Securities Thomas Flaten – Lake Street Capital Markets Saraj Kalia – Oppenheimer and Company Operator Good day, a ...